Fundraising Fox

Teresa Bitetti

Investor

President, Global Oncology Business Unit at Takeda Ventures · Board of Trustees at Northwestern Mutual Accelerator

Cambridge, Massachusetts

About

Teresa Bitetti is President of Takeda's Global Oncology Business Unit and a member of its Executive Team, overseeing therapies for gastrointestinal, thoracic, and hematological cancers across the US, Europe, and Japan. Before Takeda, she held senior oncology commercialization roles at Bristol Myers Squibb, including Head of Worldwide Oncology Commercialization and President and General Manager of BMS Canada, and earlier worked in the Capital Markets Group at Mobil Oil Corporation. She holds an MBA from the University of Virginia's Darden School of Business and a BA from Wellesley College.

Invests in

Biotech

Experience

  1. Takeda OncologyPresident Global Oncologycurrent2019 — presentCambridge, MA
  2. Northwestern MutualBoard of Trusteescurrent2025 — present
  3. Aura BiosciencesBoard of Directorscurrent2025 — present
  4. Osmol TherapeuticsBoard of Directorscurrent2022 — present
  5. Bristol-Myers SquibbSenior Vice President Worldwide Oncology Commercialization2017 — 2019Princeton, NJ
  6. Bristol-Myers SquibbSenior Vice President US Oncology2013 — 2017Princeton, NJ
  7. Bristol-Myers SquibbPresident and General Manager BMS Canada2010 — 2013Montreal, Canada
  8. Bristol-Myers SquibbVice President - Global Commercialization Virology2008 — 2010Princeton, NJ
  9. Bristol-Myers SquibbVice President Sales Neuro Science Franchise2007 — 2008Princeton, NJ
  10. Bristol-Myers SquibbVice President Marketing Neuro Science Franchise2005 — 2007Princeton, NJ
  11. Bristol-Myers SquibbRegion Vice President-Neuroscience Northeast Sales2004 — 2005Princeton, NJ
  12. Bristol-Myers SquibbSenior Director, Abilify Marketing - Neuroscience Division2001 — 2004Princeton, NJ

Skills & more

Sales1Customer ServiceCross-functional Team Leadership2Collaboration Solutions2Organizational Reengineering1Marketing Strategy2Marketing2Strategy Execution2Management7Pharmaceutical Industry8Leadership4Strategic Planning
+1 moreStrategy

From Teresa's professional profile.

Investments

Board seats

Aura Biosciences

Per the firm's website.

Colleagues at Takeda Ventures

Akiko Amakawa
CEO Chief of Staff at Takeda Ventures
Andrew S. Plump
Director - President, Research & Development at Takeda Ventures
Asuka Miyabashira
President, Japan Pharma Business Unit at Takeda Ventures
Awny Farajallah
Chief Medical Officer at Takeda Ventures
Elaine Shannon
President, Global Supply & Quality at Takeda Ventures
Gabriele Ricci
Chief Data & Technology Officer at Takeda Ventures
Giles Platford
President, International Business Unit at Takeda Ventures
Jennifer Smoter
Chief Communications & Governance Officer at Takeda Ventures

Frequently asked questions

Who is Teresa Bitetti?
Teresa Bitetti is President of Takeda's Global Oncology Business Unit and a member of its Executive Team, overseeing therapies for gastrointestinal, thoracic, and hematological cancers across the US, Europe, and Japan. Before Takeda, she held senior oncology commercialization roles at Bristol Myers Squibb, including Head of Worldwide Oncology Commercialization and President and General Manager of BMS Canada, and earlier worked in the Capital Markets Group at Mobil Oil Corporation. She holds an MBA from the University of Virginia's Darden School of Business and a BA from Wellesley College.
Where does Teresa Bitetti work?
Teresa Bitetti is President, Global Oncology Business Unit at Takeda Ventures.
What does Teresa Bitetti invest in?
Teresa Bitetti invests in Biotech.
What boards does Teresa Bitetti sit on?
Teresa Bitetti holds tracked board seats at Aura Biosciences.
Where did Teresa Bitetti go to school?
Teresa Bitetti studied at University of Virginia Darden School of Business (Master of Business Administration (M.B.A.), Finance and General Management); Wellesley College (Bachelor’s Degree, Classical Civilization).

Same school

Also attended University of Virginia Darden School of Business149

Cathy FriedmanInvestor at GV (Google Ventures)Dan LynchInvestor at GV (Google Ventures)Rajan MehraPartner at March Capital PartnersRob LudwigChief Operating Officer at Hoxton VenturesWilliam RobertsTreasurer at Maryland TEDCOJamie SerioVice President, Ventures at Capital Factory

+ 143 more

Also attended Wellesley College65

Isabelle StyslingerSenior Associate, Rise of the Rest at RevolutionCarley PhillipsPrincipal at GreycroftSusan LiuInvestment Team at 8VCKirsten LeutePartner at Osage University PartnersRudina SeseriFounder and Managing Partner at Glasswing VenturesJinho JangDirector, Quantitative Research at Deerfield Management Company

+ 59 more

Shared employers

Also worked at Takeda Oncology25

David SchenkeinInvestor at GV (Google Ventures)Kevin MunnellyInvestor at Third Rock VenturesJohn KeiltyVenture Partner at Third Rock VenturesKevin GillisPartner and Chief Operating Officer at Third Rock VenturesNeil ExterRetired Partner at Third Rock VenturesRobert TepperPartner and co-founder of Third Rock Ventures

+ 19 more

Also worked at Aura Biosciences2

Johannes FruehaufGeneral Partner at Mission BiocapitalAlan WaltsVenture Partner at Advent Life Sciences

Also worked at Bristol-Myers Squibb74

Dan LynchInvestor at GV (Google Ventures)Scott BillerInvestor at GV (Google Ventures)Avantika DaingFounding Partner at Plum Alley InvestmentsJake BauerVenture Partner at ARCH Venture PartnersScott DonohueSenior Director, Market Access at Deerfield Management CompanyBeth SeidenbergFounding Managing Director at Westlake Village BioPartners

+ 68 more